IVF hartmann Holding AG (XSWX:VBSN) EBIT: CHF21.4 Mil (TTM As of Dec. 2025)


XSWX:VBSN IVF hartmann Holding AG XSWX:VBSN
74 GF Score
Price CHF128.50
GF Value CHF143.17
Valuation Modestly Undervalued
View Full Analysis

What is IVF hartmann Holding AG EBIT?

IVF hartmann Holding AG XSWX:VBSN -1.15% 74 EBIT is CHF21.4 Mil as of Dec. 2025. GuruFocus rates XSWX:VBSN with a GF Score™ of 74/100 and a GF Value™ of CHF143.17 (Modestly Undervalued).

IVF hartmann Holding AG's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was CHF12.0 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was CHF21.4 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. IVF hartmann Holding AG's annualized ROC % for the quarter that ended in Dec. 2025 was 31.06%. IVF hartmann Holding AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 50.29%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. IVF hartmann Holding AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 10.96%.


IVF hartmann Holding AG  (XSWX:VBSN) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

IVF hartmann Holding AG's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=22.82 * ( 1 - 14.73% )/( (65.997 + 59.313)/ 2 )
=19.458614/62.655
=31.06 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=196.064 - 24.995 - ( 111.756 - max(0, 36.559 - 158.755+111.756))
=59.313

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

IVF hartmann Holding AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=23.936/( ( (35.635 + max(14.508, 0)) + (35.552 + max(9.488, 0)) )/ 2 )
=23.936/( ( 50.143 + 45.04 )/ 2 )
=23.936/47.5915
=50.29 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(22.141 + 23.846 + 0) - (20.763 + 0 + 10.716)
=14.508

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(23.474 + 21.931 + 0) - (24.995 + 0 + 10.922)
=9.488

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

IVF hartmann Holding AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=21.435/195.640
=10.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IVF hartmann Holding AG EBIT Related Terms


IVF hartmann Holding AG EBIT Historical Data

* Premium members only.

The historical data trend for IVF hartmann Holding AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IVF hartmann Holding AG EBIT Chart

IVF hartmann Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.67 13.49 17.93 24.14 21.44

IVF hartmann Holding AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.19 10.44 13.71 9.47 11.97

XSWX:VBSN vs ISRG, BDX, MDLN: EBIT Comparison

For the Medical Instruments & Supplies subindustry, IVF hartmann Holding AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IVF hartmann Holding AG EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IVF hartmann Holding AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where IVF hartmann Holding AG's EV-to-EBIT falls into.


XSWX:VBSN
74GF Score
IVF hartmann Holding AG XSWX:VBSN
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IVF hartmann Holding AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF21.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of CHF21.4 Mil mean?
IVF hartmann Holding AG (XSWX:VBSN) has a EBIT of CHF21.4 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on IVF hartmann Holding AG.
Is IVF hartmann Holding AG's EBIT too high?
IVF hartmann Holding AG's current EBIT is CHF21.4 Mil. Overall, IVF hartmann Holding AG has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IVF hartmann Holding AG's EBIT compare to ISRG and BDX?
IVF hartmann Holding AG's EBIT of CHF21.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on IVF hartmann Holding AG. IVF hartmann Holding AG's current EBIT is CHF21.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IVF hartmann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, IVF hartmann Holding AG (XSWX:VBSN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF143.17, compared to a current price of CHF128.50 — trading 10.2% below its estimated fair value. The current EBIT is CHF21.4 Mil. IVF hartmann Holding AG's overall GF Score™ is 74/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For IVF hartmann Holding AG (XSWX:VBSN), the current EBIT is CHF21.4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IVF hartmann Holding AG (XSWX:VBSN) Overvalued in 2026?

Based on GuruFocus' analysis, IVF hartmann Holding AG stock appears to be undervalued. The current stock price of CHF128.50 is trading 10.2% below its estimated GF Value™ of CHF143.17. GuruFocus considers IVF hartmann Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:VBSN:

  • EBIT: CHF21.4 Mil
  • GF Value™: CHF143.17 vs. price of CHF128.50 (10.2% below fair value)
  • GF Score™: 74/100

No single metric tells the full story. See the XSWX:VBSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IVF hartmann Holding AG Business Description

Other Exchanges VBSNz:UK0QQM:UK
Address Victor von Bruns Street 28, PO Box 634, Neuhausen, CHE, 8212
IVF hartmann Holding AG engages in production and supply of medical, pharmaceutical and hygiene products in Switzerland, it offers products such as surgical disposable, disposable dental, first aid, therapeutic plaster, cotton wool, wound care among others. The company operates in four segment wound care, incontinence management, infection management and Other group activities.
74GF Score

Get the complete analysis for XSWX:VBSN

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF128.50
Price
CHF143.17
GF Value